Switch to:

Beam Therapeutics Capital Expenditure

: $-13.21 Mil (TTM As of Mar. 2020)
View and export this data going back to 2020. Start your Free Trial

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Beam Therapeutics's cash flow for capital expenditures for the three months ended in Mar. 2020 was $-3.05 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2020 was $-13.21 Mil.


Beam Therapeutics Capital Expenditure Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Beam Therapeutics Annual Data
Dec17 Dec18 Dec19
Capital Expenditure 0.00 -13.12 -12.52

Beam Therapeutics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Capital Expenditure Premium Member Only Premium Member Only -2.35 -6.59 -1.42 -2.16 -3.05

Beam Therapeutics Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2020 was -6.585 (Jun. 2019 ) + -1.419 (Sep. 2019 ) + -2.16 (Dec. 2019 ) + -3.046 (Mar. 2020 ) = $-13.21 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Beam Therapeutics Capital Expenditure Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)